Nektar Therapeutics Inc. (NKTR)
NASDAQ · Healthcare
Nektar Therapeutics Inc. Shareholder Equity 2009–2025
Nektar Therapeutics Inc. annual shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Nektar Therapeutics Inc. shareholder equity as of December 31, 2025: 89.8M, a 47.90% increase year-over-year.
- Nektar Therapeutics Inc. shareholder equity for 2025 were 89.8M, a 47.90% increase from 2024.
- Nektar Therapeutics Inc. shareholder equity for 2024 were 60.7M, a 53.63% decrease from 2023.
- Nektar Therapeutics Inc. shareholder equity for 2023 were 131.0M, a 64.27% decrease from 2022.
- Nektar Therapeutics Inc. shareholder equity for 2022 were 366.6M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Nektar Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $90 |
| 2024 | $61 |
| 2023 | $131 |
| 2022 | $367 |
| 2021 | $680 |
| 2020 | $1,077 |
| 2019 | $1,405 |
| 2018 | $1,718 |
| 2017 | $88 |
| 2016 | $88 |
| 2015 | $6 |
| 2014 | $36 |
| 2013 | $-90 |
| 2012 | $47 |
| 2011 | $198 |
Nektar Therapeutics Inc. Shareholder Equity — FAQ
Nektar Therapeutics Inc. (NKTR) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NKTR's shareholder equity history?
The chart and table above show Nektar Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.